XML 57 R29.htm IDEA: XBRL DOCUMENT v3.7.0.1
Business Combination - Summary of Unaudited Pro Forma Information (Detail) - PharmAthene [Member] - USD ($)
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Business Acquisition [Line Items]    
Revenue and grants and contracts $ 4,443,495 $ 4,367,824
Net (loss) income attributable to common stockholders $ (6,110,625) $ 3,077,774
Weighted average common shares outstanding, basic 15,119,716 14,166,825
Net (loss) income per share, basic $ (0.40) $ 0.22
Weighted average common shares outstanding, diluted 15,119,716 15,089,819
Net (loss) income per share, diluted $ (0.40) $ 0.20